1. Home
  2. PVLA vs JMSB Comparison

PVLA vs JMSB Comparison

Compare PVLA & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • JMSB
  • Stock Information
  • Founded
  • PVLA 2015
  • JMSB 2005
  • Country
  • PVLA United States
  • JMSB United States
  • Employees
  • PVLA N/A
  • JMSB N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • JMSB Major Banks
  • Sector
  • PVLA Health Care
  • JMSB Finance
  • Exchange
  • PVLA Nasdaq
  • JMSB Nasdaq
  • Market Cap
  • PVLA 249.2M
  • JMSB 264.6M
  • IPO Year
  • PVLA N/A
  • JMSB N/A
  • Fundamental
  • Price
  • PVLA $25.92
  • JMSB $18.81
  • Analyst Decision
  • PVLA Strong Buy
  • JMSB
  • Analyst Count
  • PVLA 7
  • JMSB 0
  • Target Price
  • PVLA $46.29
  • JMSB N/A
  • AVG Volume (30 Days)
  • PVLA 129.2K
  • JMSB 21.8K
  • Earning Date
  • PVLA 08-15-2025
  • JMSB 07-23-2025
  • Dividend Yield
  • PVLA N/A
  • JMSB 1.57%
  • EPS Growth
  • PVLA N/A
  • JMSB 475.76
  • EPS
  • PVLA N/A
  • JMSB 1.24
  • Revenue
  • PVLA N/A
  • JMSB $54,782,000.00
  • Revenue This Year
  • PVLA N/A
  • JMSB N/A
  • Revenue Next Year
  • PVLA N/A
  • JMSB N/A
  • P/E Ratio
  • PVLA N/A
  • JMSB $15.45
  • Revenue Growth
  • PVLA N/A
  • JMSB 50.81
  • 52 Week Low
  • PVLA $11.17
  • JMSB $13.81
  • 52 Week High
  • PVLA $29.27
  • JMSB $26.52
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • JMSB 63.19
  • Support Level
  • PVLA N/A
  • JMSB $18.60
  • Resistance Level
  • PVLA N/A
  • JMSB $19.99
  • Average True Range (ATR)
  • PVLA 0.00
  • JMSB 0.43
  • MACD
  • PVLA 0.00
  • JMSB 0.04
  • Stochastic Oscillator
  • PVLA 0.00
  • JMSB 63.64

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

Share on Social Networks: